Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction
ABC Heart Fail Cardiomyop · 31.12.2025 · 5 (4)
DOI: 10.36660/abchf.20250018i ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC Heart Fail Cardiomyop, erschienen am 31.12.2025. Verfasst von Anderson Oliveira Estevan und 4 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Estevan, A. O., Silva, A. L. G. D. F. E., Rassi, S., Freitas, A. F. D., & Rassi, S. (2025). Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction. ABC Heart Fail Cardiomyop, 5(4). https://doi.org/10.36660/abchf.20250018i
Vancouver
Estevan AO, Silva ALGDFE, Rassi S, Freitas AFD, Rassi S. Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction. ABC Heart Fail Cardiomyop. 2025;5(4). doi:10.36660/abchf.20250018i
BibTeX
@article{Estevan2025,
author = {Estevan, Anderson Oliveira and Silva, Ana Luísa Guedes de Franca e and Rassi, Salvador and Freitas, Aguinaldo Figueiredo de and Rassi, Salvador},
title = {Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction},
journal = {ABC Heart Fail Cardiomyop},
year = {2025},
volume = {5},
number = {4},
doi = {10.36660/abchf.20250018i}
}
EUVIMED